Sammies finalist develops new drug for rare form of leukemia
Dr. Ira Pastan, Distinguished Investigator at the National Cancer Institute at NIH, discusses a drug he developed for a rare type of leukemia and its potential to treat other cancers
Dr. Ira Pastan, Distinguished Investigator at the National Cancer Institute at NIH, discusses a drug he developed for a rare type of leukemia and its potential to treat other cancers
Dr. W. Marston Linehan, chief of the Urologic Oncology Branch at the National Cancer Institute of NIH and Sammies 2019 finalist discusses his work into researching cancer causes, and how his work revolutionized treatment.
Watch on demand now presented by KPMG and ServiceNow.
Watch on demand now presented by Deloitte.
Michael Weingarten, director of the National Cancer Institute’s Small Business Innovation Research Development Center, discusses the mission of his office, and other ways the NCI is working to advance technologies that benefit cancer research.
